Logo image of STE

STERIS PLC (STE) Stock Fundamental Analysis

NYSE:STE - New York Stock Exchange, Inc. - IE00BFY8C754 - Common Stock - Currency: USD

234.065  +12.85 (+5.81%)

Fundamental Rating

6

Overall STE gets a fundamental rating of 6 out of 10. We evaluated STE against 187 industry peers in the Health Care Equipment & Supplies industry. STE has an excellent profitability rating, but there are some minor concerns on its financial health. STE has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year STE was profitable.
In the past year STE had a positive cash flow from operations.
Each year in the past 5 years STE has been profitable.
STE had a positive operating cash flow in each of the past 5 years.
STE Yearly Net Income VS EBIT VS OCF VS FCFSTE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1.2 Ratios

STE has a better Return On Assets (6.06%) than 85.56% of its industry peers.
Looking at the Return On Equity, with a value of 9.31%, STE belongs to the top of the industry, outperforming 83.42% of the companies in the same industry.
STE has a Return On Invested Capital of 8.28%. This is amongst the best in the industry. STE outperforms 88.24% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for STE is in line with the industry average of 8.28%.
The 3 year average ROIC (7.07%) for STE is below the current ROIC(8.28%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.06%
ROE 9.31%
ROIC 8.28%
ROA(3y)3.49%
ROA(5y)3.73%
ROE(3y)5.69%
ROE(5y)6.21%
ROIC(3y)7.07%
ROIC(5y)6.29%
STE Yearly ROA, ROE, ROICSTE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

With an excellent Profit Margin value of 11.26%, STE belongs to the best of the industry, outperforming 85.03% of the companies in the same industry.
STE's Profit Margin has declined in the last couple of years.
STE's Operating Margin of 17.80% is amongst the best of the industry. STE outperforms 89.30% of its industry peers.
STE's Operating Margin has been stable in the last couple of years.
The Gross Margin of STE (44.01%) is worse than 63.10% of its industry peers.
In the last couple of years the Gross Margin of STE has remained more or less at the same level.
Industry RankSector Rank
OM 17.8%
PM (TTM) 11.26%
GM 44.01%
OM growth 3Y24.25%
OM growth 5Y0.07%
PM growth 3Y28.39%
PM growth 5Y-3.5%
GM growth 3Y0.03%
GM growth 5Y0.21%
STE Yearly Profit, Operating, Gross MarginsSTE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), STE is creating some value.
STE has less shares outstanding than it did 1 year ago.
STE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for STE has been reduced compared to a year ago.
STE Yearly Shares OutstandingSTE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
STE Yearly Total Debt VS Total AssetsSTE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 5.00 indicates that STE is not in any danger for bankruptcy at the moment.
STE has a Altman-Z score of 5.00. This is in the better half of the industry: STE outperforms 78.07% of its industry peers.
The Debt to FCF ratio of STE is 2.63, which is a good value as it means it would take STE, 2.63 years of fcf income to pay off all of its debts.
STE has a better Debt to FCF ratio (2.63) than 89.30% of its industry peers.
STE has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
STE has a Debt to Equity ratio of 0.29. This is comparable to the rest of the industry: STE outperforms 48.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 2.63
Altman-Z 5
ROIC/WACC1.19
WACC6.97%
STE Yearly LT Debt VS Equity VS FCFSTE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

STE has a Current Ratio of 1.96. This is a normal value and indicates that STE is financially healthy and should not expect problems in meeting its short term obligations.
STE has a Current ratio of 1.96. This is in the lower half of the industry: STE underperforms 65.24% of its industry peers.
A Quick Ratio of 1.39 indicates that STE should not have too much problems paying its short term obligations.
STE has a Quick ratio of 1.39. This is in the lower half of the industry: STE underperforms 64.17% of its industry peers.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.39
STE Yearly Current Assets VS Current LiabilitesSTE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.35% over the past year.
The Earnings Per Share has been growing by 10.61% on average over the past years. This is quite good.
STE shows a small growth in Revenue. In the last year, the Revenue has grown by 6.24%.
STE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.49% yearly.
EPS 1Y (TTM)6.35%
EPS 3Y5.7%
EPS 5Y10.61%
EPS Q2Q%9.35%
Revenue 1Y (TTM)6.24%
Revenue growth 3Y5.99%
Revenue growth 5Y12.49%
Sales Q2Q%8.72%

3.2 Future

The Earnings Per Share is expected to grow by 6.72% on average over the next years.
The Revenue is expected to grow by 6.34% on average over the next years.
EPS Next Y8.63%
EPS Next 2Y8.67%
EPS Next 3Y8.68%
EPS Next 5Y6.72%
Revenue Next Year6.9%
Revenue Next 2Y6.48%
Revenue Next 3Y6.57%
Revenue Next 5Y6.34%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
STE Yearly Revenue VS EstimatesSTE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
STE Yearly EPS VS EstimatesSTE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 24.54, STE is valued on the expensive side.
77.54% of the companies in the same industry are more expensive than STE, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of STE to the average of the S&P500 Index (26.99), we can say STE is valued inline with the index average.
The Price/Forward Earnings ratio is 21.22, which indicates a rather expensive current valuation of STE.
78.61% of the companies in the same industry are more expensive than STE, based on the Price/Forward Earnings ratio.
STE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 36.36.
Industry RankSector Rank
PE 24.54
Fwd PE 21.22
STE Price Earnings VS Forward Price EarningsSTE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

STE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. STE is cheaper than 77.54% of the companies in the same industry.
STE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. STE is cheaper than 81.82% of the companies in the same industry.
Industry RankSector Rank
P/FCF 29.6
EV/EBITDA 16.32
STE Per share dataSTE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of STE may justify a higher PE ratio.
PEG (NY)2.84
PEG (5Y)2.31
EPS Next 2Y8.67%
EPS Next 3Y8.68%

6

5. Dividend

5.1 Amount

STE has a Yearly Dividend Yield of 1.13%.
Compared to an average industry Dividend Yield of 1.90, STE pays a better dividend. On top of this STE pays more dividend than 94.12% of the companies listed in the same industry.
With a Dividend Yield of 1.13, STE pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 1.13%

5.2 History

The dividend of STE is nicely growing with an annual growth rate of 9.04%!
STE has paid a dividend for at least 10 years, which is a reliable track record.
STE has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)9.04%
Div Incr Years19
Div Non Decr Years19
STE Yearly Dividends per shareSTE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

STE pays out 35.77% of its income as dividend. This is a sustainable payout ratio.
The dividend of STE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP35.77%
EPS Next 2Y8.67%
EPS Next 3Y8.68%
STE Yearly Income VS Free CF VS DividendSTE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
STE Dividend Payout.STE Dividend Payout, showing the Payout Ratio.STE Dividend Payout.PayoutRetained Earnings

STERIS PLC

NYSE:STE (8/7/2025, 1:39:55 PM)

234.065

+12.85 (+5.81%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners96.65%
Inst Owner Change-2.98%
Ins Owners0.21%
Ins Owner Change1.07%
Market Cap23.02B
Analysts80
Price Target273.99 (17.06%)
Short Float %0.86%
Short Ratio1.33
Dividend
Industry RankSector Rank
Dividend Yield 1.13%
Yearly Dividend2.23
Dividend Growth(5Y)9.04%
DP35.77%
Div Incr Years19
Div Non Decr Years19
Ex-Date09-04 2025-09-04 (0.63)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.75%
Min EPS beat(2)-1.06%
Max EPS beat(2)4.57%
EPS beat(4)2
Avg EPS beat(4)2.61%
Min EPS beat(4)-1.06%
Max EPS beat(4)7.17%
EPS beat(8)6
Avg EPS beat(8)3.35%
EPS beat(12)7
Avg EPS beat(12)1.79%
EPS beat(16)10
Avg EPS beat(16)3.34%
Revenue beat(2)0
Avg Revenue beat(2)-1.03%
Min Revenue beat(2)-1.82%
Max Revenue beat(2)-0.23%
Revenue beat(4)0
Avg Revenue beat(4)-0.9%
Min Revenue beat(4)-1.82%
Max Revenue beat(4)-0.23%
Revenue beat(8)3
Avg Revenue beat(8)0.77%
Revenue beat(12)4
Avg Revenue beat(12)-0.06%
Revenue beat(16)8
Avg Revenue beat(16)0.57%
PT rev (1m)0.75%
PT rev (3m)6.44%
EPS NQ rev (1m)-0.07%
EPS NQ rev (3m)-1.51%
EPS NY rev (1m)0%
EPS NY rev (3m)1.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.07%
Revenue NY rev (1m)0.15%
Revenue NY rev (3m)0.58%
Valuation
Industry RankSector Rank
PE 24.54
Fwd PE 21.22
P/S 4.22
P/FCF 29.6
P/OCF 20.06
P/B 3.49
P/tB 35.24
EV/EBITDA 16.32
EPS(TTM)9.54
EY4.08%
EPS(NY)11.03
Fwd EY4.71%
FCF(TTM)7.91
FCFY3.38%
OCF(TTM)11.67
OCFY4.99%
SpS55.5
BVpS67.13
TBVpS6.64
PEG (NY)2.84
PEG (5Y)2.31
Profitability
Industry RankSector Rank
ROA 6.06%
ROE 9.31%
ROCE 10.65%
ROIC 8.28%
ROICexc 8.44%
ROICexgc 25.17%
OM 17.8%
PM (TTM) 11.26%
GM 44.01%
FCFM 14.25%
ROA(3y)3.49%
ROA(5y)3.73%
ROE(3y)5.69%
ROE(5y)6.21%
ROIC(3y)7.07%
ROIC(5y)6.29%
ROICexc(3y)7.22%
ROICexc(5y)6.45%
ROICexgc(3y)21.51%
ROICexgc(5y)20.23%
ROCE(3y)9.09%
ROCE(5y)8.09%
ROICexcg growth 3Y22.57%
ROICexcg growth 5Y0.42%
ROICexc growth 3Y37.33%
ROICexc growth 5Y-1.39%
OM growth 3Y24.25%
OM growth 5Y0.07%
PM growth 3Y28.39%
PM growth 5Y-3.5%
GM growth 3Y0.03%
GM growth 5Y0.21%
F-Score8
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 2.63
Debt/EBITDA 1.32
Cap/Depr 77.72%
Cap/Sales 6.78%
Interest Coverage 10.87
Cash Conversion 79.28%
Profit Quality 126.58%
Current Ratio 1.96
Quick Ratio 1.39
Altman-Z 5
F-Score8
WACC6.97%
ROIC/WACC1.19
Cap/Depr(3y)68.98%
Cap/Depr(5y)73.62%
Cap/Sales(3y)7.03%
Cap/Sales(5y)7.01%
Profit Quality(3y)219.23%
Profit Quality(5y)186.77%
High Growth Momentum
Growth
EPS 1Y (TTM)6.35%
EPS 3Y5.7%
EPS 5Y10.61%
EPS Q2Q%9.35%
EPS Next Y8.63%
EPS Next 2Y8.67%
EPS Next 3Y8.68%
EPS Next 5Y6.72%
Revenue 1Y (TTM)6.24%
Revenue growth 3Y5.99%
Revenue growth 5Y12.49%
Sales Q2Q%8.72%
Revenue Next Year6.9%
Revenue Next 2Y6.48%
Revenue Next 3Y6.57%
Revenue Next 5Y6.34%
EBIT growth 1Y9.49%
EBIT growth 3Y31.69%
EBIT growth 5Y12.57%
EBIT Next Year42.03%
EBIT Next 3Y21.23%
EBIT Next 5Y15.86%
FCF growth 1Y26.93%
FCF growth 3Y25.12%
FCF growth 5Y15.65%
OCF growth 1Y17.96%
OCF growth 3Y18.8%
OCF growth 5Y14.22%